Cargando…
Impact of Extending the Timing of Maternal Pertussis Vaccination on Hospitalized Infant Pertussis in England, 2014–2018
BACKGROUND: In October 2012, a maternal pertussis vaccination program was introduced in England for women between 28 and 32 weeks of pregnancy. In April 2016, the recommended optimal window was extended to 20–32 weeks to improve vaccine coverage and protect preterm infants. This study assesses the i...
Autores principales: | Tessier, Elise, Campbell, Helen, Ribeiro, Sonia, Fry, Norman K, Brown, Colin, Stowe, Julia, Andrews, Nick, Ramsay, Mary, Amirthalingam, Gayatri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563224/ https://www.ncbi.nlm.nih.gov/pubmed/32569365 http://dx.doi.org/10.1093/cid/ciaa836 |
Ejemplares similares
-
Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019
por: Tessier, Elise, et al.
Publicado: (2021) -
Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction
por: Amirthalingam, Gayatri, et al.
Publicado: (2016) -
Accelerating Control of Pertussis in England and Wales
por: Campbell, Helen, et al.
Publicado: (2012) -
Impact of the COVID-19 pandemic on Bordetella pertussis infections in England
por: Tessier, Elise, et al.
Publicado: (2022) -
JMM Profile: Bordetella pertussis and whooping cough (pertussis): still a significant cause of infant morbidity and mortality, but vaccine-preventable
por: Fry, Norman K., et al.
Publicado: (2021)